Skip to content

Effect of Triglyceride Glucose Index on Delirium

A different factor that triggers the development of delirium in frail patients: Triglyceride Glucose index

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20240517001
Enrollment
200
Registered
2024-05-17
Start date
2024-03-31
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Frailty Intensive care Critical illness Triglyserid-glycose index Delirium Frailty Intensive care Critical illness Triglyserid-glycose index Delirium

Interventions

The patients that developed delirium,The patients that non developed delirium
Diagnostic,Diagnostic
Delirium,Non delirium

Sponsors

None,None
Collaborator

Eligibility

Sex/Gender
All
Age
65 Years to 110 Years

Inclusion criteria

Inclusion criteria: Patients aged 65 and over who are admitted to intensive care for any reason, RASS Patients with -3 and speaking Turkish were included in the study.

Exclusion criteria

Exclusion criteria: 1- Patients who stayed in intensive care for less than 24 hours (death or discharge), 2-All conditions with brain damage (such as traumatic brain injury, intracranial hemorrhage, ischemic stroke, hemorrhagic stroke, hypoxic brain injury, hepatic encephalopathy, central nervous system infections), 3-Patients with mental disorders, 4-Serious aphasia, 5- Coma state (RASS<-3), 6-Patients diagnosed with dementia or Alzheimer's, 7-Patients with hearing loss, 8-Patients with vision loss, 9-Patients who developed delirium within the first 24 hours of their stay in intensive care unit, 10-Patients for whom information regarding frailty and daily physical activities could not be obtained upon admission, 11-Patients using oral antidiabetic or lipid-lowering drugs, 12-Patients diagnosed with Diabetes Mellitus or pancreatitis, 13-Patients with pCO2 value>60 14-If the patient or his/her relatives do not accept to participate in the study,

Design outcomes

Primary

MeasureTime frame
Development of delirium six months after ICU-CAM

Secondary

MeasureTime frame
Mortality six months after Mortality rate

Countries

Turkey

Contacts

Public ContactGulsum Altuntas

Firat University

galtuntas@firat.edu.tr5416348649

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026